Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 23

Results For "Director"

3249 News Found

Morepen Labs posts strong Q4 FY26 net profit
News | May 28, 2026

Morepen Labs posts strong Q4 FY26 net profit

For the full year, standalone gross revenue crossed Rs. 1,700 crore


Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
Biopharma | May 28, 2026

Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD

Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress


Ashish Mukkirwar appointed CFO of Jubilant Pharmova
People | May 27, 2026

Ashish Mukkirwar appointed CFO of Jubilant Pharmova

The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives


Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs
Medical Device | May 27, 2026

Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs

The new facility marks Align’s first manufacturing presence in India and its fourth globally


President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy
Hospitals | May 26, 2026

President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy

The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment


International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth
News | May 26, 2026

International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth

Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023


China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer
Drug Approval | May 26, 2026

China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer

The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer


Datroway wins US nod in aggressive breast cancer subtype
Drug Approval | May 25, 2026

Datroway wins US nod in aggressive breast cancer subtype

Clearance marks major shift beyond chemotherapy


SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth
News | May 25, 2026

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore